Rigel Pharmaceuticals RIGL Single reportable segment — Interest Income (Expense), Operating

Similar metrics at other companies

ROSTReportable Segment — Interest Income (Expense), Operating

$33.45M-2.8%

RLJReportable Segment — Interest Income (Expense), Nonoperating

-$24.74M-1.8%

ACELReportable Segment — Interest Income (Expense), Nonoperating

-$8.5M+2.1%

FULTReportable Segment — Interest Income (Expense), Operating

$259.09M+7.9%

PFSReportable Segment — Interest Income (Expense), Operating

$193.74M+6.6%

MMIReportable Segment — Interest Expense, Operating

$153K-18.2%

Other financials

Income statement

See full

Revenue$58.8M+10.3%

Gross profit$54.2M+10.8%

Operating income$11.9M-7.0%

Net income$8.7M-24.4%

EPS (diluted)$0.44-30.2%

Balance sheet

See full

Cash & equivalents$24.5M-46.6%

Total debt$68.4M+5,079%

Total equity$399.9M+2,054%

Total assets$504.6M+187%

Cash flow

See full

Operating cash flow$2.7M+405%

CapEx$73.0K—

Free cash flow-$22.0M—

Valuation

See full

Market cap$684.39M+102%

Enterprise value$728.29M+148%

P/E1.9×-7.2×

P/S2.3×+0.6×

Profitability

See full

Gross margin93.4%+3.7pp

Operating margin41.6%+19.9pp

Net margin121.5%+103pp

FCF margin-61.7%—

Returns & leverage

See full

Return on equity174.1%—

Debt / equity0.2×+0.1×

Current ratio2.6×+0.4×

Where this comes from

Reported directly by Rigel Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:InterestIncomeExpenseNet.

The official record: Rigel Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rigel Pharmaceuticals's single reportable segment — interest income (expense), operating.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Rigel Pharmaceuticals's single reportable segment — interest income (expense), operating?: Rigel Pharmaceuticals (RIGL) reported single reportable segment — interest income (expense), operating of -$228K in Q1 2026.
What does single reportable segment — interest income (expense), operating mean?: Reflects the net interest income or expense generated from the segment's operating activities, such as cash management or financing arrangements. It provides insight into the segment's financial leverage and capital structure efficiency.